UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043734
Receipt number R000049933
Scientific Title A, randomized, controlled clinical trial to evaluate efficacy of EHL under cholangioscopy versus EPLBD including cost-effectiveness
Date of disclosure of the study information 2021/04/01
Last modified on 2021/03/25 12:54:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A, randomized, controlled clinical trial to evaluate efficacy of EHL under cholangioscopy versus EPLBD including cost-effectiveness

Acronym

A, randomized, controlled clinical trial to evaluate efficacy of EHL under cholangioscopy versus EPLBD including cost-effectiveness

Scientific Title

A, randomized, controlled clinical trial to evaluate efficacy of EHL under cholangioscopy versus EPLBD including cost-effectiveness

Scientific Title:Acronym

A, randomized, controlled clinical trial to evaluate efficacy of EHL under cholangioscopy versus EPLBD including cost-effectiveness

Region

Japan


Condition

Condition

Common bile duct stone

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Technical success rate

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Complete stone clearance rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver Other

Interventions/Control_1

EHL vs EPLBD

Interventions/Control_2

Age

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Common bile duct stone with accessible papilla

Key exclusion criteria

Surgical altered anatomy

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Ogura

Organization

Osaka Medical College

Division name

2nd Department of Internal Medicine

Zip code

5698686

Address

2-7 Daigakuchou, Takatsukishi

TEL

072-683-1221

Email

in2121@osaka-med.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Ogura

Organization

Osaka Medical College

Division name

2nd Department of Internal Medicine

Zip code

569-8686

Address

2-7 Daigakuchou, Takatsukishi

TEL

072-683-1221

Homepage URL


Email

in2121@osaka-med.ac.jp


Sponsor or person

Institute

Osaka Medical College

Institute

Department

Personal name



Funding Source

Organization

Osaka Medical College

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Medical College

Address

2-7 Daigakuchou, Takatsukishi

Tel

072-683-1221

Email

in2121@osaka-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 02 Month 01 Day

Date of IRB

2021 Year 03 Month 23 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2023 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 03 Month 25 Day

Last modified on

2021 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049933


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name